Stocklytics Platform
Asset logo for symbol HIMS
Hims & Hers Health
HIMS71
$22.11arrow_drop_down4.32%-$1.00
High Growth
Asset logo for symbol HIMS
HIMS71

$22.11

arrow_drop_down4.32%
Key Stats
Open$22.72
Prev. Close$23.11
EPS-0.01
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range21.96
23.33
52 Week Range5.65
25.74
Ratios
EPS-0.01
Fundamentals
Payout Ratio-
Industry average yield2.92%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

HIMSarrow_drop_down4.39%
US Consumer Defensive Sectorarrow_drop_up0.27%
US Marketarrow_drop_up0.68%
warning
HIMS / Market
HIMS lose to the US Market which returned 0.68% over the last twenty four hours.
warning
HIMS / Consumer Defensive Sector
HIMS lose to the US Consumer Defensive sector which returned 0.27% over the last twenty four hours.

Hims & Hers Health (HIMS) Statistics

Hims & Hers Health, Inc. (HIMS) is a company focused on providing telehealth and wellness products and services. The company offers a range of healthcare solutions, including prescriptions for common medical conditions, over-the-counter products, and personalized treatment plans. With its online platform, Hims & Hers aims to make healthcare more accessible and convenient for individuals. The company's stock statistics provide valuable insights into its performance in the market. Investors can analyze key metrics such as the stock's valuation and fundamentals to make informed investment decisions.

When it comes to valuation metrics, Hims & Hers Health, Inc. is evaluated based on various factors. These include the company's market capitalization, price-to-earnings ratio, and price-to-sales ratio. These metrics help investors understand the stock's relative value and potential for growth. Additionally, the company's fundamentals provide vital information about its financial health and stability. This includes metrics such as revenue per share, enterprise to EBITDA (earnings before interest, taxes, depreciation, and amortization), profit margin, total debt, and gross profit. These metrics can help investors assess the company's profitability, efficiency, and leverage.

add Hims & Hers Health to watchlist

Keep an eye on Hims & Hers Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has Hims & Hers Health (HIMS) stock's performance compared to its sector and the market over the past year?

Over the past year, Hims & Hers Health (HIMS) has experienced a price change of . Compared to the Consumer Defensive sector, which saw a change of 28.03%, Hims & Hers Health has underperformed compared to its sector, indicating its relative standing within the Consumer Defensive sector. Against the broader market's change of 14.04%, it has fallen short of the market average. This comparison highlights Hims & Hers Health's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of Hims & Hers Health (HIMS) stock?

The PE ratio for Hims & Hers Health (HIMS) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

help
What is the EPS of Hims & Hers Health (HIMS) stock?

The Earnings Per Share (EPS) for Hims & Hers Health (HIMS), calculated on a diluted basis, is -$0.01. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of Hims & Hers Health (HIMS) stock?

The operating margin for Hims & Hers Health (HIMS) is 3.59%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of Hims & Hers Health (HIMS) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Hims & Hers Health (HIMS) is $5.2M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does Hims & Hers Health (HIMS) have?

Hims & Hers Health (HIMS) has a total debt of $11.82M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$93.41M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level